Skip to content
The Policy VaultThe Policy Vault

Ofev (nintedanib)United Healthcare

Idiopathic pulmonary fibrosis (IPF)

Initial criteria

  • Diagnosis of idiopathic pulmonary fibrosis (IPF) as documented by all of the following:
  • Exclusion of other known causes of interstitial lung disease (e.g., domestic and occupational environmental exposures, connective tissue disease, drug toxicity)
  • ICD-10 Code J84.112 (Idiopathic pulmonary fibrosis)
  • One of the following:
  • In patients not subjected to surgical lung biopsy: presence of a usual interstitial pneumonia (UIP) pattern on HRCT revealing IPF or probable IPF
  • In patients subjected to a lung biopsy: both HRCT and surgical lung biopsy pattern reveal IPF or probable IPF
  • If request is for Esbriet, Esbriet is not used in combination with Ofev
  • If request is for Ofev, Ofev is not used in combination with Esbriet
  • Prescriber is a pulmonologist

Reauthorization criteria

  • Documentation of positive clinical response to Esbriet or Ofev therapy, as applicable
  • If Esbriet: not used in combination with Ofev
  • If Ofev: not used in combination with Esbriet

Approval duration

12 months